Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Molecular targeting drugs--present status and future development].

Michihiko Kuwano1, Teruhiko Fujii, Mayumi Ono

  • 1Research Center for Innovative Cancer Therapy, Kurume University.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|July 31, 2004
PubMed
Summary

Molecular targeting drugs offer novel cancer therapies by targeting specific molecules like EGF receptor. Further research is needed to determine efficacy, identify new targets, and optimize combination therapies.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Pulmonary responses to polyacrylic acid with and without carboxyl groups following intratracheal instillation in rats.

Archives of toxicology·2026
Same author

[Biological effects of lunar regolith dust].

Sangyo eiseigaku zasshi = Journal of occupational health·2026
Same author

[Factors that contribute to the death/severity and onset of COVID-19 infection in working generation: Investigation of general health examination items by narrative review].

Sangyo eiseigaku zasshi = Journal of occupational health·2026
Same author

Aberrant Hippo-YAP/TEAD Signaling Drives Malignant Transcriptional Reprogramming in External Auditory Canal Squamous Cell Carcinoma.

Cancer research communications·2026
Same author

Polyacrylic acid, but not polyethylene glycol, induces metabolic reprogramming linked to pulmonary fibrosis in rats.

Scientific reports·2025
Same author

The fourth nationwide surveillance of antimicrobial susceptibility against Neisseria gonorrhoeae from male urethritis in Japan, 2021.

Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy·2025

Area of Science:

  • Oncology
  • Pharmacology
  • Molecular Biology

Context:

  • Molecular targeting drugs represent a significant advancement in cancer therapy.
  • Numerous molecular targets, including EGF receptor family proteins, Bcr-abl, CD20, and Ras, are being investigated for drug development.
  • Several targeted drugs are currently approved or in clinical trials for cancer treatment.

Purpose:

  • To highlight the potential of molecular targeting drugs in cancer therapeutics.
  • To identify key challenges and future research directions in the field.
  • To address critical questions regarding evidence-based efficacy determination, promising new targets, and optimal combination therapy design.

Summary:

  • Molecular targeting drugs exploit specific molecules driving cancer malignancy.

Related Experiment Videos

  • Approved and investigational drugs target key molecules like EGF receptor, Bcr-abl, CD20, and Ras.
  • Overcoming challenges in efficacy assessment, target identification, and combination therapy is crucial for advancing this strategy.

    • Impact:

    • Molecular targeting drugs offer a novel therapeutic strategy for cancer patients.
    • Continued research is essential to refine treatment protocols and expand the application of targeted therapies.
    • Addressing current limitations will enhance the effectiveness and applicability of molecularly targeted cancer treatments.